Thank you for attending!
2024 Annual New York State
Hepatitis C & Drug User Health Conference
September 11, 2024
Thank You!
We are pleased to offer attendees based in New York State a copy of our plenary speaker, Maia Szalavitz’s new book, “Undoing Drugs: How Harm Reduction Is Changing the Future of Drugs and Addiction.”
If you would like to receive a copy, please click below: https://www.surveymonkey.com/r/2024HCVDUH_Conference
About
Us
The Clinical Education Initiative (CEI)'s Hepatitis C and Drug User Health Center of Excellence is a New York State Department of Health AIDS Institute program that offers free continuing medical education to enhance the capacity of New York State's diverse healthcare workforce to deliver high-quality clinical services and improve patient outcomes. We offer online live and on-demand trainings, intensive preceptorship programs, targeted technical assistance, free clinical tools and more.
The 2024 annual New York State Hepatitis C and Drug User Health conference is a free, full-day, virtual program intended for clinical prescribers throughout the state.
A recording of the 2024 annual New York State Hepatitis C and Drug User Health conference will be available on our website shortly, please check back soon.
Visit CEI online and follow us on social media
September 11, 2024 • 8:45am-4:00pm
Click on Session Titles to access slides and resources!
Session Type | Session Title | Speaker(s) | |
8:45-9:00 | Introduction | Lauren Walker, MPH • Linda Wang, MD | |
9:00-9:45 | Plenary | Maia Szalavitz | |
9:45-10:45 | Concurrent Didactic Breakouts (Select One) | Benjamin Eckhardt, MD, MS • Colleen Flanigan, RN, MS • Tatyana Kushner, MD, MSCE | |
Matthew Fallico, MSW • Emily Payne, MSPH | |||
10:45-11:45 | Break | ||
11:00-12:30 | Panel Discussion | Emma Fabian, MSW • Sharon Stancliff, MD, FAAFP, DFASAM • Justine Waldman, MD, FACEP | |
12:30-1:30 | Working Lunch | Join us for lunch to learn about three innovative programs and interact with our clinical experts! | La Bodega Model of Care Scott Springer, PA • Anthony Martinez, MD, AAHIVS, FAASLD |
Community Voices Felecia Pullen, PhD | |||
MATTERS Network Joshua Lynch, DO, FACEP, FAAEM, FAMPA | |||
1:30-2:30 | Concurrent Didactic Breakouts (Select One) | Rebekah Joab, JD • Alexandra Warren, JD | |
Aarathi Nagaraja, MD, CHP | |||
2:30-4:00 | Panel Discussion | Tiffany Lu, MD, MS • Ashley Magnussen, CRPA • Kelly Ramsey, MD, MPH, MA, FACP, DFASAM • Sara Lorenz Taki, MD • Kristine Torres-Lockhart, MD |
Speakers
Plenary Session:
Harm Reduction
Maia Szalavitz
Author
Maia Szalavitz is the author, most recently, of Undoing Drugs: The Untold Story of Harm Reduction and the Future of Addiction, which is the first history of the movement aimed at focusing policy on minimizing harms, not highs. She writes regularly for the New York Times and has written for numerous publications including TIME, Wired, the Nation, Vice and Scientific American.
Maia’s New York Times bestseller, Unbroken Brain: A Revolutionary New Way of Understanding Addiction wove together neuroscience and social science with her personal experience of addiction. It won the 2018 media award from the National Institute on Drug Abuse. And her 2006 book, Help at Any Cost: How the Troubled Teen Industry Cons Parents and Hurts Kids, was the first to expose the damage caused by “tough love” youth treatment and helped spur Congressional hearings. She has also authored or co-authored five other books, including the classic on child trauma, The Boy Who Was Raised as a Dog, with Dr. Bruce D. Perry. With Dr. Perry, she has also written Born for Love: Why Empathy Is Essential— And Endangered, which laid out why empathy is essential for social trust and how inequality can erode it. With Dr. Joseph Volpicelli, she wrote Recovery Options: The Complete Guide, the first evidence-based guide to addiction treatment. Maia lives with her husband and two squeaky cats in New York City.
Speakers
Morning Didactic Breakout Sessions •
Select One
- Implementing New Hepatitis C Tools and Policies
- Drug Checking in New York State
Benjamin Eckhardt, MD, mS
Assistant Professor of Medicine • New York University Grossman School of Medicine
Benjamin Eckhardt received his MD degree from Albert Einstein College of Medicine and Internal Medicine training at New York University within the Primary Care Program. After completing residency, he worked in Rwanda for Partners In Health/Inshuti Mu Buzima with a clinical appointment at Brigham and Women’s Hospital and Harvard Medical School. He returned to New York to complete his fellowship training in Infectious Diseases at Weill Cornell Medical College while concurrently receiving a MS in Clinical Epidemiology and Health Services Research. Dr. Eckhardt joined the faculty at NYU/Bellevue in 2016 with a clinical focus in HIV and hepatitis management. His research interest focuses on evaluating models of care to facilitate access, engagement, and retention of active injection drug users in HCV treatment and care.
Colleen Flanigan, RN, MS
Director, Bureau of Hepatitis Health Care and Epidmiology • New York State Department of Health, AIDS Institute
Colleen Flanigan currently serves as the Director of the Bureau of Hepatitis Health Care and Epidemiology at the New York State Department of Health AIDS Institute. Ms. Flanigan has been involved in hepatitis C-related work for two decades. She directs the hepatitis C programmatic and policy work and the hepatitis B and C surveillance activities for New York State. Ms. Flanigan is also responsible for the implementation and monitoring of the New York State Hepatitis C Elimination Plan. Ms. Flanigan holds a Bachelor’s degree in Biology and a Master’s degree in Nursing.
Tatyana Kushner, MD, MSCE
Associate Professor of Medicine • Division of Liver Diseases, Icahn School of Medicine at Mount Sinai
Dr. Tatyana Kushner is Associate Professor in the Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai in New York, with a joint appointment in the department of Obstetrics and Gynecology. Dr. Kushner’s clinical and research interests focus on clinical predictors, epidemiological trends and outcomes in viral hepatitis and in liver disease during pregnancy. Her clinical practice encompasses the full spectrum of liver disease from metabolic dysfunction-associated steatohepatitis (MASH, previously known as non-alcoholic steatohepatitis or NASH) to cirrhosis and decompensated liver disease. She is a member of the AASLD/IDSA HCV Guidance committee, advisor to the CDC Coalition for Global Hepatitis Elimination Tip-HepC Registry and advisor to the Hepatitis C Mentor and Support Group.
Matthew Fallico, MSW
Health Program Manager • New York State Department of Health, AIDS Institute Office of Drug User Health
Mr. Fallico is a Health Program Manager with the New York State Department of Health AIDS Institute, Office of Drug User Health. Within the Office of Drug User Health, he oversees the implementation and management of the Drug User Health Drug Checking program. His additional duties include overseeing the fiscal, operational and planning aspects of the New York MATTERS program. Mr. Fallico received his Master’s in Social Work at Arizona State University with a concentration in program planning and community practice.
Emily Payne, MSPH
Epidemiologist and Program Evaluator • New York State Department of Health, AIDS Institute Office of Drug User Health
Emily Payne, MSPH, is an Epidemiologist and Program Evaluator at the New York State Department of Health AIDS Institute, Office of Program Evaluation and Research. Her work focuses on programs serving people who use drugs including drug checking, naloxone distribution and administration, and referrals to opioid treatment programs. Prior to joining the New York State Department of Health in 2021, Emily worked as an epidemiologist at the state and local levels in Colorado.
Speakers
Buprenorphine Treatment
Morning Panel Session:
Emma Fabian, MSW
Associate Director of Harm Reduction • Evergreen Health
Click to learn more about Evergreen
Emma Fabian is the Associate Vice President of Harm Reduction at Evergreen Health in Western New York. Formerly AIDS Community Services, Evergreen Health was founded over 40 years ago during the height of the global HIV/AIDS epidemic and now provides a range of medical, behavioral, and supportive services to individuals and families in the region. In her position at Evergreen Health, Emma oversees harm reduction and drug user health services, including syringe exchange, low-threshold buprenorphine, drop-in services, wound care, and more. She participates in several local and statewide workgroups addressing issues that impact people who use drugs. Emma holds a Bachelor of Arts from Canisius University and Master of Social Work degree from SUNY University at Buffalo where she also currently serves as a part-time instructor. She enjoys talking to all types of audiences about harm reduction, drug use, and related topics.
Sharon Stancliff, MD, FAAFP, DFASAM
Associate Director for Harm Reduction in Health Care • New York State Department of Health, AIDS Institute Office of the Medical Director
Sharon Stancliff is Associate Medical Director for Harm Reduction in Health Care at the AIDS Institute, New York State Department of Health. She also serves as a staff physician for a federally qualified health center, where she provides
addiction services.
Dr. Stancliff has been working with people who use drugs since 1990 including the provision of primary care, drug treatment, HIV care and harm reduction. Her current focus is on opioid overdose prevention through expanding access to buprenorphine treatment and naloxone. She has spoken and provided technical assistance both nationally and internationally, and has authored numerous books and peer reviewed journal articles. Dr. Stancliff maintains board certification in Family Medicine and Addiction Medicine.
Justine Waldman, MD, FACEP
Chief Executive Officer and Chief Medical Officer • REACH Medical
Click to learn more about REACH
Justine Waldman is board certified in Addiction Medicine and Emergency Medicine, and is a Fellow of the American College of Emergency Physicians. In 2018, she founded REACH Medical in Ithaca, which offers integrated primary care and low threshold harm reduction services for people who tend to face stigma in the current medical system. In addition to primary care, REACH Medical provides MOUD, viral screening, vaccination and treatment, and on-demand behavioral health care. REACH also has a robust outreach program staffed by individuals with lived experience who offer services and support via telehealth. REACH serves as the Ithaca Law Enforcement Assisted Diversion (LEAD) Program administrative home for case management, and has an established Peer Advisory Board that provides stipends to peers through a local foundation grant to advise REACH on various aspects of the organization.
Speakers
Working Lunch:
Ask The Experts
The “La Bodega” Model of care
Anthony Martinez,
MD, AAHIVS, FAASLD
Medical Director, Hepatology • Erie County Medical Center
Dr. Martinez’s clinic, “La Bodega,” has been recognized nationally and internationally as a novel colocalized model for managing viral hepatitis and addiction disorders.
Dr. Martinez has been a primary and co-investigator on numerous clinical trials related to hepatitis C and fatty liver disease. He is board-certified by the ABIM and the American Academy of HIV Medicine. He is a Fellow of the American Association for the Study of Liver Disease, ambassador and co-chair of the Chronic Liver Disease Foundation HCV Committee, and an inductee in the Gold Humanism Honor Society.
Scott Springer, PA
Physician Assistant,
Hepatology • Erie County Medical Center
Scott R. Springer is a certified physician assistant at Erie County Medical Center's Center for Hepatology Care, also known as “La Bodega”. He cares for patients with liver disease and substance use disorders. Scott has presented on the treatment of hepatitis C virus (HCV) at the local, state, and national levels and educates medical providers from throughout New York State on the clinical management of HCV. Scott is a founding member of ECMC’s Harm Reduction Coalition and has been named an 2024 Emerging Liver APP by the American Association for the Study of Liver Disease.
Click to learn more about “La Bodega”
“La Bodega” provides cutting edge, compassionate care for patients with liver disease. Their specialists offer personalized, innovative treatment and therapeutics for patients with liver disease.
Felecia Pullen,
PhD
Founder, President & Chief Executive Officer • Let’s Talk SAFETY, Inc.
Dr. Felecia Pullen founded and is the President & CEO of Let’s Talk SAFETY, Inc., a not-for-profit which includes: SAFE in Harlem, a SAMHSA-funded teen-led substance misuse prevention coalition; The PILLARS, Manhattan’s first OASAS-funded Recovery Community & Outreach Center; and The SAFETY Net, a teen-designed Clubhouse in Harlem. Each division offers holistic, complementary and alternative approaches to recovery, for individuals and family members who are loving someone in active use.
Dr. P specializes in program and policy development for the fields of substance use disorders, teen misuse prevention, non-medical models of harm reduction, and recovery support. Much of her focus is on the design and implementation of community-based initiatives. Through multi-tiered approaches, she believes we can prevent the onset of use, reduce overdoses resulting from misuse, increase the attainment of recovery capital, and promote healthier communities. Her advocacy and activism has been recognized nationally and throughout New York City and State. She has delivered numerous workshops in Culturally Responsive Recovery at SAMHSA’s National Leadership Forum; has twice been appointed by former NYC Mayor Bill DeBlasio to the City’s Municipal Drug Strategy Council; currently sits on the FOR-NY Recovery Community Steering Committee, and has produced several substance misuse awareness campaigns for the State.
Through the strength of her partnerships with NYPD, The NYC Dept of Health & Mental Hygiene,Colleges and Universities, Public and private healthcare systems, and political figures, Dr. P has delivered programs and services *free of charge* to over 20,000 individuals. Her work is inspired by the vision of a drug-misuse-free world ... One child, one family, and one community at a time!
Joshua Lynch, DO, FACEP, FAAEM, FAMPA
Associate Professor of Emergency Medicine • University at Buffalo Jacobs School of Medicine and Biomedical Sciences
A native of Buffalo, New York, Dr. Joshua Lynch is a leader and expert in the areas of emergency medicine and treatment of opioid use disorder. He completed his undergraduate studies at the University at Buffalo, graduating with a BS in psychology. Dr. Lynch then attended the Lake Erie College of Osteopathic Medicine as part of the inaugural class at the Bradenton, Florida campus. At LECOM, he played a key role in establishing the brand-new medical school within the community. He completed an emergency medicine residency at the University at Buffalo, where he served as chief resident his final year. Dr. Lynch serves as a Trustee on the Board of Education for Clarence Central Schools and a Board Member of United Way of Buffalo and Erie County. He also serves as the Chief Medical Officer for the Medication for Addiction Treatment & Electronic Referrals (MATTERS) Network.
MATTERS facilitates rapid referrals for individuals with opioid use disorder by connecting participating referral sites, receiving treatment organizations, peer support agencies, and pharmacies all into one efficient process.
Watch the 60-second clip to the left to learn more about who they are & what they do.
Speakers
Afternoon Didactic Breakout Sessions •
Select One
- Legal Advocacy for Patients Who Use Drugs
- Integrating Clinical Care for Hepatitis C and Infectious Diseases
Rebekah Joab, JD
Senior Staff Attorney • Legal Action Center (LAC)
As a Senior Staff Attorney, Rebekah Joab advocates for individuals who have experienced discrimination because of their substance use, arrest or conviction records, and HIV or AIDS status. Rebekah works on LAC's impact litigation and direct legal services across these areas, with a particular focus on LAC’s legal strategies to increase access to medication for opioid use disorder and enforce anti-discrimination rights for people who use drugs. During her time at LAC, Rebekah has litigated Finnigan v. Mendrick et. al., which challenged a jail’s ban on medication for opioid use disorder, written amicus briefs in several cases challenging discrimination against people with substance use disorders, and contributed to articles such as Ending Medical Complicity With Skilled-Nursing Facility Discrimination Against People With Opioid Use Disorder. In her role at LAC, Rebekah also educates and trains organizations and individuals about anti-discrimination and other laws protecting LAC's constituencies. Rebekah earned her BA in psychology from the University of Maryland, College Park, and her JD from the Georgetown University Law Center.
Alexandra Warren, JD
Staff Attorney • Legal Action Center (LAC)
Alexandra is LAC's Staff Attorney for the Community Health Access to Addiction and Mental Healthcare Project in NYS (CHAMP). She provides legal counsel and technical assistance to stakeholders on substance use disorder (SUD)-related issues, develops multimedia educational materials, and conducts trainings on the Mental Health Parity and Addiction Equity Act and other SUD-related issues. Additionally, she represents select clients by drafting insurance appeals and complaints regarding parity violations and emergency department care denials. Alexandra received her J.D. from Northeastern University School of Law. Her internship experience includes assistance on a class action lawsuit for the medical rights of people incarcerated at Louisiana State Penitentiary, direct representation for unhoused LGBTQ+ youth in New York City, and assistance on a Massachusetts Drug Court reform project. She received a B.A. in Anthropology from American University.
Aarathi Nagaraja, MD, CHP
Quality Medical Director of HIV and Hepatitis Programs • Sun River Health
Dr. Nagaraja is the Quality Medical Director of HIV and Hepatitis Programs at Sun River Health, a large federally ualified health center that covers Hudson Valley, Long Island and New York City. She is an Infectious Disease physician who provides HIV, Hepatitis B/C care, and Medication Assisted Treatment for Opioid Use Disorder within an integrated primary care model at Sun River Health. Dr. Nagaraja works closely with her care teams to oversee the quality of the HIV and Hepatitis programs at Sun River Health. She is also the co-chair for NYS Congenital Syphilis Elimination Strategic Planning group.
Speakers
Afternoon Panel Session:
Methadone Regulation
Tiffany Lu, MD, MS
Associate Professor of Medicine • Albert Einstein College of Medicine
-
Associate Director of Addiction Services • New York City Health+Hospitals/Jacobi
Ashley Magnussen, CRPA
Kelly Ramsey, MD, MPH, MA, FACP, DFASAM
Sara Lorenz Taki, MD
Chief Medical Officer • Greenwich House
Hepatitis C Peer Advocate • Greenwich House
Addiction Medicine and Harm Reduction Consultant
Click to learn more about Greenwich House
Kristine Torres-Lockhart, MD
Assistant Professor | Physician • Albert Einstein College of Medicine | Montefiore Medical Center
Tiffany Lu is an Associate Professor of Medicine and Psychiatry at the Albert Einstein College of Medicine in Bronx, New York. She joined New York City Health & Hospitals/Jacobi in 2024 as Associate Director of Addiction Services, where she is currently focused on developing a hospital-based opioid treatment program and integrating harm reduction practices in caring for people with substance use disorders. Prior to joining Jacobi, Dr. Lu was the Medical Director of Montefiore Medical Center’s Buprenorphine Treatment Network, where she led the implementation of primary care-based opioid use disorder treatment across seven community health centers. She also founded the Addiction Medicine ‘Bridge’ Clinic at Montefiore to provide coordinated care people with substance use disorders. Dr. Lu graduated from the University of California in San Francisco School of Medicine and the Primary Care Internal Medicine Residency Program at Massachusetts General Hospital. She holds a Masters of Science in Clinical Research Methods from Albert Einstein College of Medicine. She is board certified in Internal Medicine and Addiction Medicine, and is active with the American Society of Addiction Medicine as an elected member of the Quality Improvement Council and Education Committee Chair for the state chapter.
Sara Lorenz Taki serves as the Chief Medical Officer for Greenwich House and sits on the Clinical Advisory Panel for OASAS and the Substance Use Guidelines Committee for the New York State Department of Health AIDS Institute. At Greenwich House, she provides medical direction for all healthcare services, including mental health treatment, treatment for substance use disorders, psychiatric services, hepatitis C treatment, overdose prevention, harm reduction, and older adult services. Dr. Taki obtained her medical degree from the University of Wisconsin School of Medicine and Public Health and completed residency training at Montefiore. She is board-certified in Addiction Medicine and Internal Medicine. She trains healthcare providers and students from multiple medical institutions on the treatment of substance use disorders and hepatitis C.
Ashley Magnussen is a certified recovery peer advocate who specializes in hepatitis C at Greenwich House Center for Healing. She is born and raised in Broad Channel, Queens and is the mother of two girls. Ashley is most passionate about the community she serves and will do anything possible to make sure their voices are heard.
Kristine Torres-Lockhart is a general internist, primary care provider and addiction medicine specialist. She focuses on caring for people who use substances and people with substance use disorders, providing care in hospital settings and in outpatient clinics. Dr. Torres-Lockhart serves as Director of the Addiction Medicine Fellowship Program at Montefiore Einstein, founding director of the Addiction Consult Service at Weiler Hospital, and Assistant Professor of Medicine in the Division of General Internal Medicine and Psychiatry and Behavioral Sciences at Albert Einstein College of Medicine. After obtaining her Bachelor of Arts in neuroscience from Dartmouth College in 2010, Dr. Torres-Lockhart earned her Doctor of Medicine at the Geisel School of Medicine at Dartmouth in 2016. She completed an internship and residency in internal medicine and primary care at Brigham and Women’s Hospital in 2019 and completed a fellowship in addiction medicine at Montefiore Einstein in 2020. Dr. Torres-Lockhart is board certified by the American Board of Internal Medicine and the American Board of Preventive Medicine with certification in Addiction Medicine. She is also a Fellow of the American Society of Addiction Medicine and a board member of the New York Society of Addiction Medicine and member the Association for Multidisciplinary Education and Research in Substance Use and Addiction. In 2022, Dr. Torres-Lockhart received the President’s Award at the New York Society of Addiction Medicine’s Annual Conference. In 2023, she received the Quality Improvement Champion honor at the United Hospital Fund's Tribute to Excellence in Health Care and was a Rising Star Nominee for the Department of Medicine’s Physician Recognition Awards at Montefiore Einstein.
Kelly Ramsey is a board certified internal medicine and addiction medicine physician who has treated substance use disorder since 2004. She worked as Medical Director of an academic center-based opioid treatment program (OTP) in the South Bronx before working for nearly a decade for a large federally qualified health center in the Hudson Valley where she created and grew a medication for addiction treatment (MAT) program for opioid use disorder and alcohol use disorder to 10 sites and 1,500 patients. More recently, Dr. Ramsey worked as the Chief of Medical Services at the NYS Office of Addiction Services and Supports, in a policy, regulatory, and clinical role. As an Addiction Medicine and Harm Reduction Consultant, Dr. Ramsey provides low threshold clinical care and clinical supervision in addiction medicine in two drug user health hubs in New York. She has provided expert advice to the New York State Department of Health AIDS Institute and their Office of Drug User Health in addiction medicine, harm reduction, HIV, and hepatitis C care. In December 2018, Dr. Ramsey was the recipient of the New York State Commissioner’s Special Recognition Award for contributions to drug user health in New York State. Dr. Ramsey was the Distinguished Contributions to Behavioral Medicine Award Recipient, awarded by the American College of Physicians (ACP) in April 2023. In October 2023, she was awarded the Case Western Reserve University School of MedicineSpecial Medical AlumniBoard Award. Dr. Ramsey is the Immediate Past President for the New York Chapter of the American Society of Addiction Medicine (NYSAM) Board of Directors. In addition, she currently serves as Region I Director, representing NYS, on the national American Society of Addiction Medicine (ASAM) Board of Directors.
Continuing Medical
Education
Free credit made available by the New York State Department of Health AIDS Institute:
- 6.75 CME
- 6.75(3.5Rx) CNE
- 6.75 CPE
Attendees will receive an email with a link to complete evaluation and claim CE credit through the myCEI platform
Please claim credit by Wednesday, September 25th
Accreditation Statements
CME Accreditation/Certification:
The University of Rochester School of Medicine and Dentistry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Rochester School of Medicine and Dentistry designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Statement:
The University of Rochester Center for Nursing Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
6.75 (3.5Rx) Nursing Contact Hours will be provided.
CPE Statement:
The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been accredited as a knowledge-based activity. Credit will be uploaded to the CPE Monitor to those who complete all components of this activity. No partial credit is available.
ACPE# 0044-9999-24-024-L01-P, 6.75 contact hours, 0.675 CEUs.
Financial Relationships of Planners
The following presenters and others have either indicated financial relationships with ineligible companies or that no financial relationships exist. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education.
The following planners do not have any relevant financial relationships with ineligible companies:
Lauren Walker, MPH; Jeffrey Weiss, PhD; Linda Wang, MD;
Oksana Babiy, BS; Monica Barbosu, MD, PhD; Tamara Eis, MS, RN-BC
No commercial funding was received to support this activity.
Financial Relationships of Speakers
The following presenters and others have either indicated financial relationships with ineligible companies or that no financial relationships exist. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education.
The following speakers do not have any relevant financial relationships with ineligible companies:
Maia Szalavitz; Colleen Flanigan, RN, MS; Emily Payne, MSPH; Sharon Stancliff, MD, FAAFP, DFASAM; Emma Fabian; Justine Waldman, MD, FACEP; Felecia Pullen, PhD; Rebekah Joab, JD; Alexandra Warren, JD; Kelly Ramsey, MD, MPH, MA, FACP, DFASAM; Tiffany Lu, MD, MS; Sara Lorenz Taki, MD; Kristine Torres-Lockhart, MD; Ashley Magnussen
The following speakers have disclosed financial relationships:
Benjamin Eckhardt, MD, MS | Gilead Sciences Inc., Research grant paid to institution
Tatyana Kushner, MD, MSCE | AbbVie, Consultant; Bausch, Advisor; Eiger, Advisor; Gilead, Advisor, Research Support; GSK, Consultant
Matthew Fallico, MSW | Klinic Care, Consultant
Scott Springer, PA | AbbVie, Speaker, Consultant; Gilead, Speaker, Consultant
Anthony Martinez, MD, AAHIVS, FAASLD | AbbVie, Speaker, Consultant, Researcher; Allergan, Researcher; Antios, Consultant; Eisai, Consultant; Gilead, Speaker, Consultant, Researcher; Intercept, Consultant, Researcher; VBI/Syneos, Speaker; Arbutus, Consultant; Madrigal, Consultant/Speaker; Braeburn, Speaker
Joshua Lynch, DO, FACEP, FAAEM, FAMPA | Emergen Biosolutions, Advisor (no relationship currently)
Aarathi Nagaraja, MD, CPH | Gilead, Hepatitis C Virus Division, Speaker
All of the relevant financial relationships listed above have been mitigated.
No commercial funding was received to support this activity.
Resources
Scan or Click to Order!
Clinical cards for harm reduction and buprenorphine available free of charge for New York State-based clinicians.
The Conversations with CEI podcast features our clinical experts discussing current health issues while providing the latest news and guidelines in our areas of expertise.
Toll-free line available for New York State-based physicians with clinical questions regarding hepatitis C, the care and treatment of people who use drugs and more.
Visit CEI online and follow us on social media
Clinical Education with CEI
Tailored trainings in-person and online
On-demand webinars
Hands-on clinical preceptorship programs
If you are interested in scheduling a training or webinar for your organization, please contact us!
Visit CEI online and follow us on social media
Live Graphic Recording
A live artist from The Sketch Effect will join our program to bring information to life with graphic recorings!
Graphic recording creates a visual representation of presentations that can help gain insight into complex concepts.
Last year, our live artist created the image to the right based on our plenary talk featuring Dr. Jonathan Giftos.
FAQs
How do I get my certificate of attendance?
Attendance is tracked through our online myCEI system. To access a certificate of attendance after the conference, please log in online.
Will I receive a copy of the slides?
Yes! A copy of each presentation will be available online after the conference. Check back here for a direct link.
Will the conference be recorded? How can I access a copy?
The conference is being recorded, and will be available on-demand on CEI’s website after the conference.
Will attendees receive related materials and/or resources after the conference?
Yes! Attendees will have an opportunity to request CEI materials, clinical resources and a copy of Maia Szalavitz’s book Undoing Drugs: The Untold Story of Harm Reduction and the Future of Addiction. Please check back for details.
Are you offering continuing medical education credit?
The program is accredited for 6.75 CME, CNE, CPE and 3.5 CNERx credits. Attendees will receive an email with a link to claim credit through the myCEI platform.
2024 Annual New York State
Hepatitis C & Drug User Health Conference
Full-day Virtual Program
Wednesday, September 11, 2024 • 8:45am-4:00pm
Questions?